MYELOID MALIGNANCY
Clinical trials for MYELOID MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new MYELOID MALIGNANCY trials appear
Sign up with your email to follow new studies for MYELOID MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat blood cancer patients in major drug trial
Disease control Recruiting nowThis study is testing the safety and dosing of a new oral drug called lisaftoclax, both by itself and combined with other cancer drugs, for people with acute myeloid leukemia (AML) that has returned or not responded to prior treatment. The goal is to find the safest and most effe…
Matched conditions: MYELOID MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New approach aims to keep transplant working longer for blood cancer patients
Disease control Recruiting nowThis study is testing whether giving the drug azacitidine after a stem cell transplant can help maintain the donor's healthy cells in patients with blood cancers like AML and MDS. The goal is to reduce the risk of the cancer returning by preventing the patient's own cells from ta…
Matched conditions: MYELOID MALIGNANCY
Phase: PHASE2 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for tough blood cancers: experimental combo targets resistant leukemia
Disease control Recruiting nowThis study is testing whether a new three-drug combination can help control acute myeloid leukemia (AML) that has returned or hasn't responded to previous treatments. The trial will enroll 72 adults with relapsed or refractory AML to receive the drug combination and closely monit…
Matched conditions: MYELOID MALIGNANCY
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
Scientists test drug combo to boost Cancer-Killing transplant
Disease control Recruiting nowThis early-stage trial is testing if adding two anti-cancer drugs, decitabine and venetoclax, to a standard stem cell transplant procedure is safe for adults with high-risk blood cancers like acute myeloid leukemia (AML). The main goal is to find the safest dose and see if this c…
Matched conditions: MYELOID MALIGNANCY
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Mar 10, 2026 12:54 UTC
-
Virtual chats aim to ease anxiety for seniors facing serious blood cancers
Symptom relief Recruiting nowThis study is testing whether a telehealth program helps older patients with serious blood cancers have better conversations with their doctors about future care wishes. It aims to see if these structured video calls reduce patient anxiety and distress, and help more people compl…
Matched conditions: MYELOID MALIGNANCY
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Mar 30, 2026 14:27 UTC
-
Digital stories aim to ease the agony of a Life-or-Death cancer decision
Symptom relief Recruiting nowThis study is testing a new digital program designed to help patients with serious blood cancers make a difficult decision about a stem cell transplant. The program shows video stories from people who have faced the same choice and includes exercises to help patients clarify what…
Matched conditions: MYELOID MALIGNANCY
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC
-
Genetic sleuthing aims to catch blood cancers before they start
Knowledge-focused Recruiting nowThis study aims to find people at risk for developing blood cancers and bone marrow failure syndromes before they get sick. Researchers will use advanced genetic testing on blood, bone marrow, and saliva samples from up to 2,000 participants. The goal is to identify early warning…
Matched conditions: MYELOID MALIGNANCY
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC